High-flow oxygen for painful sickle cell episodes
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests whether giving high-flow oxygen can help treat a painful sickle cell “vaso-occlusive crisis” (VOC) and lower the risk of a serious lung complication. You may be eligible if you’re an adult with sickle cell disease experiencing an opioid-requiring pain flare and have higher risk for lung trouble.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have major sickle cell disease (SS, SC, or S-beta zero/plus types)
- You are having an acute pain episode (VOC) that needs opioid pain medicine
- You are at higher risk for a lung complication (based on blood counts and certain exam findings, or partly based on hydroxyurea use)
- You can give informed consent (and meet local social security/coverage rules)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if iloprost, a medicine that helps open blood vessels, can reduce pain from a sickle cell crisis. It's for adults with sickle cell disease who need to be in the hospital for strong pain medicine.
This study tests an investigational medicine called osivelotor for people with sickle cell disease (SCD). The goal is to see if it can reduce pain crises and improve overall health. It is for adults and adolescents aged 12 and older.
This trial tests if an intravenous medication called L-citrulline can help treat pain crises in children and young adults with sickle cell disease. Participants receive either the study drug or a placebo while in the hospital for a severe pain episode.
This study tests if using a bedside ultrasound (a quick, painless scan) of the chest and lungs can help doctors better understand and manage pain crises in people with sickle cell disease. If you are in the hospital for a severe pain crisis, you may be able to join.
This trial tests an IV medication called L-citrulline for children, teens, and young adults (ages 6–21) with sickle cell disease who are having a sudden, severe pain crisis (called a vaso-occlusive crisis). The goal is to see if it helps relieve pain quickly.
This trial is testing a way to safely reduce high-flow oxygen therapy for patients in the ICU who have low oxygen levels. It might help find the right time to stop this treatment.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.